GB1475806A - Halogen-pyrazole derivatives a method for producing them and medicaments containing them - Google Patents
Halogen-pyrazole derivatives a method for producing them and medicaments containing themInfo
- Publication number
- GB1475806A GB1475806A GB3574074A GB3574074A GB1475806A GB 1475806 A GB1475806 A GB 1475806A GB 3574074 A GB3574074 A GB 3574074A GB 3574074 A GB3574074 A GB 3574074A GB 1475806 A GB1475806 A GB 1475806A
- Authority
- GB
- United Kingdom
- Prior art keywords
- halogen
- derivatives
- aug
- pharmaceutical compositions
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1475806 Pharmaceutical compositions of 5- Halo-1, 3-diphenyl pyrazole-4-acetic acids BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 14 Aug 1974 [16 Aug 1973] 35740/74 Heading A5B [Also in Division C2] Pharmaceutical compositions comprising a compound of the formula I in which Ph 1 and Ph 2 are the same or different phenyl radicals in which the substituents thereon, where present, are not hydrolysable and halogen is a fluorine chlorine or bromine atom or their salts with organic or inorganic bases and a pharmaceutically acceptable medicament vehicle show anti-inflammatory, antipyretic and analgesic activity when administered orally, parenterally, topically or rectally. The compositions may also contain other inflammatory agents such as a corticosteroid, analgesics, particularly pyrazolone derivatives e.g. prednisolone and dexamethasone, muscle relaxants such as pyridazine derivatives and carbamates, antiulcerogenics, antiacid materials such as magnesium trisilicate and aluminium hydroxide, substances which encourage local blood circulation such as nicotinic acid derivatives and dimethyl sulphoxide, local anesthetics such as lidocain and vitamins.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU68238A LU68238A1 (en) | 1973-08-16 | 1973-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1475806A true GB1475806A (en) | 1977-06-10 |
Family
ID=19727442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3574074A Expired GB1475806A (en) | 1973-08-16 | 1974-08-14 | Halogen-pyrazole derivatives a method for producing them and medicaments containing them |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5230515B2 (en) |
AT (1) | AT339892B (en) |
BE (1) | BE818912A (en) |
CA (1) | CA1048499A (en) |
CH (1) | CH601250A5 (en) |
DE (2) | DE2462459C3 (en) |
DK (1) | DK136953B (en) |
ES (1) | ES429247A1 (en) |
FI (1) | FI57584C (en) |
FR (1) | FR2240732B1 (en) |
GB (1) | GB1475806A (en) |
IE (1) | IE39999B1 (en) |
LU (1) | LU68238A1 (en) |
NL (1) | NL169070C (en) |
NO (1) | NO140733C (en) |
SE (1) | SE409454B (en) |
YU (1) | YU222474A (en) |
ZA (1) | ZA745252B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5297383A (en) * | 1976-02-13 | 1977-08-16 | Ngk Spark Plug Co | Ceramic honeycomb structures for exhaust gas purification |
HUP0304101A3 (en) * | 2003-12-22 | 2008-10-28 | Sanofi Aventis | Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
-
1973
- 1973-08-16 LU LU68238A patent/LU68238A1/xx unknown
-
1974
- 1974-08-13 DE DE2462459A patent/DE2462459C3/en not_active Expired
- 1974-08-13 DE DE2438779A patent/DE2438779C3/en not_active Expired
- 1974-08-14 CH CH1111874A patent/CH601250A5/xx not_active IP Right Cessation
- 1974-08-14 ES ES429247A patent/ES429247A1/en not_active Expired
- 1974-08-14 FR FR7428162A patent/FR2240732B1/fr not_active Expired
- 1974-08-14 GB GB3574074A patent/GB1475806A/en not_active Expired
- 1974-08-14 YU YU02224/74A patent/YU222474A/en unknown
- 1974-08-15 NL NLAANVRAGE7410921,A patent/NL169070C/en not_active IP Right Cessation
- 1974-08-15 ZA ZA00745252A patent/ZA745252B/en unknown
- 1974-08-15 DK DK438174AA patent/DK136953B/en unknown
- 1974-08-15 SE SE7410419A patent/SE409454B/en unknown
- 1974-08-15 IE IE1705/74A patent/IE39999B1/en unknown
- 1974-08-15 FI FI2422/74A patent/FI57584C/en active
- 1974-08-15 NO NO742941A patent/NO140733C/en unknown
- 1974-08-15 JP JP49093786A patent/JPS5230515B2/ja not_active Expired
- 1974-08-15 CA CA74207072A patent/CA1048499A/en not_active Expired
- 1974-08-16 BE BE147661A patent/BE818912A/en unknown
- 1974-08-16 AT AT671174A patent/AT339892B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI57584B (en) | 1980-05-30 |
DK136953C (en) | 1978-05-29 |
FI242274A (en) | 1975-02-17 |
AT339892B (en) | 1977-11-10 |
SE7410419L (en) | 1975-02-17 |
DE2462459A1 (en) | 1977-04-07 |
IE39999L (en) | 1975-02-16 |
BE818912A (en) | 1975-02-17 |
LU68238A1 (en) | 1975-05-21 |
NO140733B (en) | 1979-07-23 |
CH601250A5 (en) | 1978-06-30 |
DE2438779C3 (en) | 1979-09-20 |
DE2438779B2 (en) | 1979-01-25 |
ZA745252B (en) | 1976-03-31 |
ES429247A1 (en) | 1976-08-16 |
DE2462459C3 (en) | 1979-10-04 |
SE409454B (en) | 1979-08-20 |
FR2240732A1 (en) | 1975-03-14 |
DK438174A (en) | 1975-04-28 |
JPS5049278A (en) | 1975-05-01 |
NL169070B (en) | 1982-01-04 |
NL7410921A (en) | 1975-02-18 |
FR2240732B1 (en) | 1978-07-21 |
DE2438779A1 (en) | 1975-02-27 |
JPS5230515B2 (en) | 1977-08-09 |
DE2462459B2 (en) | 1979-02-08 |
DK136953B (en) | 1977-12-19 |
ATA671174A (en) | 1977-03-15 |
FI57584C (en) | 1980-09-10 |
CA1048499A (en) | 1979-02-13 |
YU222474A (en) | 1983-04-27 |
NO140733C (en) | 1979-10-31 |
IE39999B1 (en) | 1979-02-14 |
NO742941L (en) | 1975-03-17 |
NL169070C (en) | 1982-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4016268A (en) | Method of combatting gastric ulceration | |
GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
US3564100A (en) | Basically substituted cycloalkene compounds as antitussive agents | |
ES431425A1 (en) | M-phenoxyphenyl propionic acid derivatives and preparation thereof | |
IE40791B1 (en) | Vincamine derivatives | |
GB1475806A (en) | Halogen-pyrazole derivatives a method for producing them and medicaments containing them | |
EP0206076A2 (en) | 1,8-Bridged 4-quinolone-3-carboxylic acids, process for their preparation as well as medicaments containing them, and their use for the preparation of medicaments | |
US3139381A (en) | Process of effecting diuresis with nitro disulfamylaniline compounds | |
US4256747A (en) | Antiphlogistic pharmaceutical compositions and method of use | |
IE40893B1 (en) | 1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents | |
US3060090A (en) | Pyrazolidine-quinazolone therapeutic composition | |
GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
GB1399469A (en) | Amino derivatives of pyrazolopyridine ketones | |
GB1351505A (en) | Terpene derivatives method for their preparation and applications thereof | |
CA1056306A (en) | Pharmaceutical compositions containing 2-naphthyl-butyric acid derivatives | |
GB1181967A (en) | Novel Picoline Derivatives and a Method for the Production Thereof | |
US3269909A (en) | Analgesic methods and compositions of benzoic acid derivatives | |
GB1174880A (en) | Derivatives of alpha-Piperazinophenylacetonitrile and process for manufacture of same | |
US4621085A (en) | 2,4,7-triamino-6-phenylpteridine | |
US3692827A (en) | Derivatives of aminoalkanoic acids | |
GB1382996A (en) | Substituted biphenyls | |
GB1497004A (en) | 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and esters thereof and their preparation | |
US5128330A (en) | Oxazinone substituted phosphines | |
US3726913A (en) | Derivatives of aminoalkanoic acids | |
GB1186061A (en) | Benzonaphthyridine Derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |